![](/img/cover-not-exists.png)
Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntingtonâs Disease PatientsâA Randomized Phase 2 Clinical Trial
Brownstein, Michael J., Simon, Neal G., Long, Jeffrey D., Yankey, Jon, Maibach, Hilda T., Cudkowicz, Merit, Coffey, Christopher, Conwit, Robin A., Lungu, Codrin, Anderson, Karen E., Hersch, Steven M.,Volume:
9
Journal:
Journal of Clinical Medicine
DOI:
10.3390/jcm9113682
Date:
November, 2020
File:
PDF, 519 KB
2020